Page 23 - Read Online

Page 18 of 18 Cheng et al. J Cancer Metastasis Treat 2021;7:17 https://dx.doi.org/10.20517/2394-4722.2021.27

73. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the
MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001;16:1486-95.
DOI PubMed
74. Funk JL, Wei H. Regulation of parathyroid hormone-related protein expression in MCF-7 breast carcinoma cells by estrogen and
antiestrogens. Biochem Biophys Res Commun 1998;251:849-54. DOI PubMed
75. Black DM, Rosen CJ. Clinical practice: postmenopausal osteoporosis. N Engl J Med 2016;374:254-62. DOI PubMed
76. Cancer Stat Facts: Female Breast Cancer Subtypes. Natl Cancer Inst Surveillance, Epidemiol End Results Progr n.d.
https://seer.cancer.gov/statfacts/html/breast-subtypes.html. [Last accessed on 30 Mar 2021].
77. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005;353:793-
802. DOI PubMed
78. Braun S, Auer D, Marth C. The prognostic impact of bone marrow micrometastases in women with breast cancer. Cancer Invest
2009;27:598-603. DOI PubMed
79. Hussein O, Komarova SV. Breast cancer at bone metastatic sites: recent discoveries and treatment targets. J Cell Commun Signal
2011;5:85-99. DOI PubMed PMC
80. Falck AK, Bendahl PO, Ingvar C, et al. Analysis of and prognostic information from disseminated tumour cells in bone marrow in
primary breast cancer: a prospective observational study. BMC Cancer 2012;12:403. DOI PubMed PMC
81. Brown HK, Allocca G, Ottewell PD, et al. Parathyroid hormone (PTH) increases skeletal tumour growth and alters tumour distribution
in an in vivo model of breast cancer. Int J Mol Sci 2018;19:2920. DOI PubMed PMC
82. Swami S, Johnson J, Bettinson LA, et al. Prevention of breast cancer skeletal metastases with parathyroid hormone. JCI Insight
2017;2:90874. DOI PubMed PMC
83. Jiang G, Zhang S, Yazdanparast A, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast
cancer. BMC Genomics 2016;17:525. DOI PubMed PMC
84. Sasaki A, Boyce BF, Story B, et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Cancer Res 1995;55:3551-7. PubMed
85. Holen I, Speirs V, Morrissey B, Blyth K. In vivo models in breast cancer research: progress, challenges and future directions. Dis
Model Mech 2017;10:359-71. DOI PubMed PMC
86. Murayama T, Gotoh N. Patient-derived Xenograft models of breast cancer and their application. Cells 2019;8:621. DOI PubMed
PMC
87. Dobrolecki LE, Airhart SD, Alferez DG, et al. Patient-derived xenograft (PDX) models in basic and translational breast cancer
research. Cancer Metastasis Rev 2016;35:547-73. DOI PubMed PMC
88. Matthews SB, Sartorius CA. Steroid hormone receptor positive breast cancer patient-derived Xenografts. Horm Cancer 2017;8:4-15.
DOI PubMed PMC
89. Yin JJ, Mohammad KS, Käkönen SM, et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc
Natl Acad Sci U S A 2003;100:10954-9. DOI PubMed PMC